Principal Financial Group Inc Iovance Biotherapeutics, Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$7.28 - $11.9 $10.9 Million - $17.8 Million	1,496,941 Added 59.02%	4,033,184 $37.9 Million
Q2 2024 Jul 29, 2024	BUY	$7.78 - $14.19 $4.13 Million - $7.53 Million	530,338 Added 26.44%	2,536,243 $20.3 Million
Q1 2024 Apr 29, 2024	SELL	$7.59 - $17.47 $4.78 Million - $11 Million	-630,422 Reduced 23.91%	2,005,905 $29.7 Million
Q4 2023 Feb 07, 2024	SELL	$3.3 - $8.89 $22,532 - $60,700	-6,828 Reduced 0.26%	2,636,327 $21.4 Million
Q3 2023 Nov 02, 2023	BUY	$4.44 - $8.79 $3.43 Million - $6.79 Million	772,905 Added 41.33%	2,643,155 $12 Million
Q2 2023 Aug 07, 2023	SELL	$5.36 - $9.06 $227,917 - $385,249	-42,522 Reduced 2.22%	1,870,250 $13.2 Million
Q1 2023 May 09, 2023	BUY	$5.53 - $8.22 $4.87 Million - $7.24 Million	881,181 Added 85.42%	1,912,772 $11.7 Million
Q4 2022 Feb 09, 2023	SELL	$5.62 - $10.0 $201,426 - $358,410	-35,841 Reduced 3.36%	1,031,591 $6.59 Million
Q3 2022 Nov 09, 2022	BUY	$9.53 - $13.11 $1.44 Million - $1.98 Million	150,749 Added 16.45%	1,067,432 $10.2 Million
Q2 2022 Aug 10, 2022	BUY	$6.38 - $18.33 $2.23 Million - $6.42 Million	350,025 Added 61.77%	916,683 $10.1 Million
Q1 2022 May 09, 2022	BUY	$12.38 - $19.1 $62,778 - $96,856	5,071 Added 0.9%	566,658 $9.44 Million
Q4 2021 Feb 09, 2022	BUY	$16.55 - $27.63 $243,616 - $406,713	14,720 Added 2.69%	561,587 $10.7 Million
Q3 2021 Nov 09, 2021	BUY	$20.35 - $26.63 $443,304 - $580,107	21,784 Added 4.15%	546,867 $13.5 Million
Q2 2021 Aug 10, 2021	BUY	$16.33 - $33.07 $1.73 Million - $3.51 Million	106,211 Added 25.36%	525,083 $13.7 Million
Q1 2021 May 10, 2021	BUY	$28.67 - $52.59 $1.07 Million - $1.97 Million	37,419 Added 9.81%	418,872 $13.3 Million
Q4 2020 Feb 08, 2021	BUY	$28.04 - $50.26 $302,243 - $541,752	10,779 Added 2.91%	381,453 $17.7 Million
Q3 2020 Nov 06, 2020	BUY	$27.75 - $36.3 $22,366 - $29,257	806 Added 0.22%	370,674 $12.2 Million
Q2 2020 Aug 05, 2020	BUY	$27.21 - $41.0 $4.86 Million - $7.33 Million	178,760 Added 93.54%	369,868 $10.2 Million
Q1 2020 May 12, 2020	BUY	$19.54 - $38.85 $1.74 Million - $3.45 Million	88,858 Added 86.9%	191,108 $5.72 Million
Q4 2019 Feb 05, 2020	BUY	$17.95 - $29.41 $1.18 Million - $1.93 Million	65,635 Added 179.26%	102,250 $2.83 Million
Q3 2019 Nov 13, 2019	BUY	$17.99 - $26.0 $59,420 - $85,878	3,303 Added 9.92%	36,615 $666,000
Q2 2019 Aug 12, 2019	BUY	$9.78 - $24.52 $40,049 - $100,409	4,095 Added 14.02%	33,312 $817,000
Q1 2019 May 10, 2019	BUY	$8.41 - $11.26 $36,331 - $48,643	4,320 Added 17.35%	29,217 $278,000
Q4 2018 Feb 14, 2019	SELL	$7.51 - $11.93 $32,570 - $51,740	-4,337 Reduced 14.84%	24,897 $220,000
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $46,215 - $72,711	4,108 Added 16.35%	29,234 $329,000
Q2 2018 Aug 13, 2018	BUY	$12.45 - $16.95 $312,818 - $425,885	25,126 New	25,126 $0

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.16B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account